Skip to content

Author

A. Gorantla

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 8452: Beta-Blocker Therapy and Atrioventricular Conduction Outcomes in Heart Failure with Reduced Ejection Fraction and Fascicular Block

Background: Beta-blockers are a cornerstone of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF). However, their safety in patients with pre-existing fascicular or bundle-branch block remains uncertain because of potential adverse effects on atrioventricular (AV) conduction....

M. Fahim, A. Gorantla, Daoud Eldawud et al. · 0 citations
Review Open access Oct 2026

Imaging the invisible: comparative diagnostic accuracy of cardiac imaging techniques for amyloidosis

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that is underdiagnosed until advanced stages. Non-invasive imaging modalities, including echocardiography, cardiovascular magnetic resonance (CMR), bone scintigraphy, positron emission tomography (PET), and computed tomography (CT), have transformed diagn...

K. Singhal, V. Patel, N. Doobay et al. · 0 citations
Open access Oct 2026

Left Atrial Appendage Occlusion versus Oral Anticoagulation in Atrial Fibrillation: A Meta-Analysis of Randomized Trials.

BACKGROUND Emergence of direct oral anticoagulants as the first-line therapy for stroke prevention in nonvalvular atrial fibrillation has redefined the comparator benchmark for left atrial appendage occlusion (LAAO). OBJECTIVES The objective of the study was to compare the efficacy and temporal safety of LAAO vs oral...

A. D. Babu, S. Cameron, Haroon Gill et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.